Article

Acceptance of the HPV Vaccine for Adolescent Girls: Analysis of State-Added Questions from the BRFSS

Markey Cancer Control Program, University of Kentucky, Lexington, Kentucky 40504-3381, USA.
Journal of Adolescent Health (Impact Factor: 3.61). 06/2009; 44(5):437-45. DOI: 10.1016/j.jadohealth.2008.09.001
Source: PubMed

ABSTRACT

Previous research regarding human papillomavirus (HPV) awareness and vaccine acceptance has relied on convenience or other selected samples of the population. To assess the prevalence of HPV awareness and vaccine acceptance in Kentucky we added questions to the 2006 Kentucky Behavioral Risk Factor Survey System (BRFSS), a population-based survey of health behaviors.
Women who participated in the statewide BRFSS were asked two HPV-related questions: one assessed previous awareness of HPV, and another assessed vaccine acceptance for girls 10 to 15 years old. We used crosstabulations and multivariate logistic regression to determine which factors were associated with HPV awareness and vaccine acceptance. Because the HPV vaccine Gardasil was approved in June 2006, we conducted an analysis of pre- and postapproval HPV awareness and vaccine acceptance. We also compared results across Appalachian and non-Appalachian counties, two distinct regions of Kentucky.
Overall, 57.6% of women had heard of HPV, and 70.2% accepted vaccination for girls. HPV awareness increased after Gardasil's approval, but the increase was much smaller among Appalachian women. Prevalence of vaccine acceptance was unchanged in both regions. Awareness of HPV was not associated with vaccine acceptance, and factors significantly associated with vaccine acceptance in multivariate analysis differed by Appalachian status.
This population-based survey of Kentucky women found relatively high vaccine acceptance for girls. Also, many respondents reported not knowing whether they accept vaccination, and factors associated with vaccine acceptance varied by Appalachian status. These findings suggest that acceptance of the HPV vaccine for girls may improve with targeted interventions.

Download full-text

Full-text

Available from: W. Jay Christian, Aug 07, 2014
  • Source
    • "Previous studies on the knowledge of HPV infection and vaccines; and acceptability of HPV vaccines among health care providers and the public have shown varied results (Makwe CC 2011, Jain N 2009, Dursun P 2009, Christian WJ 2009, Klug SJ 2008, Riedesel JM 2005, Daley MF 2006, Songthap A 2009, Kwan TT 2009, Jones M 2008) (Tozzi AE 2009). Majority of these studies are however from developed countries. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Availability of effective vaccine against cervical cancer is not synonymous with effective control program. Awareness and knowledge of the vaccine is pertinent to its uptake. It is important to identify possible barriers to successful HPV vaccination program among young people. Materials and Methods A cross-sectional study of 572 female students selected by probability sampling technique from two Universities in South West, Nigeria was carried with the use of self-administered questionnaire. Results The proportion of respondents who were able to correctly identify risk factors for cervical cancer ranged from 14.3% (increasing age) to 53.5% (Chlamydia infection). Less than 50% of the participants were found to be knowledgeable about all the knowledge themes except the preventable nature of cervical cancer of which 62.9% were knowledgeable. The commonest sources of information were health care providers and seminars (44.1% each). Three hundred and forty-six (60.5%) respondents were willing to receive the vaccine. Age, faculty, age at menarche, awareness of HPV infection and cervical cancer; and all the knowledge themes except the need for male vaccination shows statistically significant relationship with acceptability of HPV vaccine (p < 0.05). Possible barrier to successful implementation of HPV vaccination program among young people in Nigeria were also identified. Inadequate information was thought to be the major barrier (68.9%). The other barriers were cost (38.1%), worry about possible complications (15.0%) and vaccine efficacy (13.3%); and lack of parental consent for vaccination (12.9%). Conclusion Knowledge of HPV vaccine is poor but its acceptability is high. Successful HPV vaccination program will depend on innovative and multi-pronged campaign that addresses various misconceptions about the vaccine. Economic accessibility of the vaccines also needs to be enhanced.
    Full-text · Article · Nov 2015 · International Journal of Advanced Research
  • Source
    • "vaccine (Gardasil) and bivalent vaccine (Cevarix). In June 2006, after the US Food and Drug Administration licensed, these vaccines have been recommended for girls between the ages of 9-26 in many European countries, in New Zealand, Australia, and in the USA within the context of various school immunization programs (Markowitz et al., 2007; Christian et al., 2009; Weisberg et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Human papilloma virus (HPV) is one of the most common sexually transmitted agents and its infection is the most established cause of cervical cancer. Midwives play a key position in the implementation of cervical cancer. This descriptive study aimed to determine the level of knowledge concerning HPV and HPV vaccination among 268 midwifery students. Data were collected between November 15 and 30, 2011, through a self-reported questionnaire. The mean age of participants was 20.75±1.60. Among all students, 44.4% had heard of HPV, while 40.4% had heard of HPV vaccinatiob. The relationship between the midwifery student knowledge on HPV and HPV vaccine and their current educational year was significant (p=0.001). In conclusion midwifery students have moderate level of knowledge about HPV and its vaccine and relevant information should be included in their teaching curriculum.
    Preview · Article · Nov 2013 · Asian Pacific journal of cancer prevention: APJCP
  • Source
    • "This study found that awareness of HPV ( 26% ) and HPV vaccine ( 21 . 7% ) were low in comparison to previous studies which reported higher rate of awareness ranged from 57 . 6% to 84 . 3% ( Jain et al . , 2009 and Christian et al . , 2009 ) . However , low level of knowledge was found by some previous studies from Malaysia ( Wong , 2008 ) and other countries ( Giles & Garland , 2006 ; Moreira et al . , 2006 ; Donders et al . , 2008 ; Vanslyke et al . , 2008 ) . For example , a study in Norway showed that only 20% of women had heard about HPV ( Kahn et al . , 2003 ) . Len"
    [Show abstract] [Hide abstract]
    ABSTRACT: A cross-sectional study was conducted among 300 Malaysian women in the obstetrics and gynecology outpatient clinic in a selected hospital in Bangi, Selangor to determine the level of knowledge of HPV and HPV vaccines, attitudes toward HPV vaccination and barriers of being vaccinated. Factors associated with knowledge and attitudes were also addressed with a questionnaire. Seventy eight women (26%) had heard about the HPV virus and 65 about HPV vaccines (21.7%). Marital status was associated significantly with awareness of HPV and HPV vaccine (p=0.002, p=0.002; respectively), in addition to level of education (p=0.042). The percentages of women who reported correct answers for the questions on knowledge of HPV and HPV vaccine ranged from 12% to 25%. One hundred fifty nine respondents (53%) had a positive attitude toward HPV vaccination. Age, marital status, and level of education were associated significantly with attitude (p<0.001, p<0.001, p=0.002; respectively). The most important barriers reported were 'unawareness of the vaccine' 'concerned about side effects' and 'afraid of needles'. This study found a very low level of knowledge of HPV and HPV vaccine. Education of population is highly recommended and barriers to being vaccinated should be dealt with seriously.
    Full-text · Article · Jan 2010 · Asian Pacific journal of cancer prevention: APJCP
Show more